Discovery of novel AHLs as potent antiproliferative agents

Eur J Med Chem. 2015 Mar 26:93:321-9. doi: 10.1016/j.ejmech.2015.02.026. Epub 2015 Feb 19.

Abstract

Three series of novel AHL analogs were synthesized and evaluated for their in vitro cytotoxic activity against four human cancer cell lines. The SARs investigation indicated that AHLs with a terminal phenyl group, especially those with the chalcone scaffold had remarkably enhanced cytotoxicity than those with the hydrophobic side chains. Besides, some of these compounds were much more potent than 5-Fu and natural OdDHL. Through the detailed SARs discussions, we found that compounds 10a-k and 14 with the 4-amino chalcone scaffold showed excellent inhibition against all the tested cancer cell lines and were much more potent than 5-Fu and AHLs. Such scaffold may act as a template for further lead optimization. Compound 10i with a 3, 4, 5-trimethoxy group was the most potent one against all the tested cancer cell lines. Flow cytometry analysis indicated that analog 11e induced the cellular apoptosis and cell cycle arrest of MCF-7 cells at G2/M phase in a concentration-and time-dependent manner.

Keywords: AHLs; Apoptosis; Cell cycle arrest; Chalcones; Cytotoxicity; Dithiocarbamates.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyl-Butyrolactones / chemistry*
  • Acyl-Butyrolactones / pharmacology*
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Cell Cycle / drug effects
  • Cell Proliferation / drug effects
  • Chalcone / chemistry
  • Drug Design*
  • Humans
  • Inhibitory Concentration 50
  • MCF-7 Cells
  • Structure-Activity Relationship

Substances

  • Acyl-Butyrolactones
  • Antineoplastic Agents
  • Chalcone